KI
Kestrel Investment Management Corp
13F filer · CIK 0000917579Reported Aug 4, 2026
Net buyer this quarter
13F portfolio value$184MU.S. long equity reported on 13F
Positions403 new · 2 closed
Net flow last quarter+$631KBuys minus sells
Top 10 positions weight43.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 4, 202640 positions | |||||
| $13.5M | 7.33% | 0.44% | -0.1% | Q3 2023 | |
| $9.27M | 5.04% | 0.17% | Not reported | Q2 2023 | |
| $7.81M | 4.25% | 0.17% | Not reported | Q1 2015 | |
| $7.76M | 4.23% | 0.22% | Not reported | Q1 2026 | |
| $7.31M | 3.98% | 0.21% | Not reported | Q2 2013 | |
| $7.02M | 3.82% | 0.22% | Not reported | Q4 2025 | |
| $6.81M | 3.71% | 0.21% | Not reported | Q4 2023 | |
| $6.73M | 3.67% | 0.42% | Not reported | Q1 2026 | |
| $6.52M | 3.55% | 0.34% | Not reported | Q4 2024 | |
| $6.47M | 3.52% | 0.16% | +141.9% | Q1 2026 | |
| $6M | 3.27% | 0.32% | Not reported | Q1 2015 | |
| $5.9M | 3.21% | 0.14% | Not reported | Q2 2022 | |
| $5.72M | 3.12% | 0.16% | Not reported | Q1 2021 | |
| $5.64M | 3.07% | 0.22% | Not reported | Q1 2025 | |
| $5.42M | 2.95% | 0.34% | Not reported | Q4 2025 | |
| $5.36M | 2.92% | 0.44% | Not reported | Q3 2025 | |
| $5.21M | 2.83% | 0.11% | New | Q2 2026 | |
| $5.08M | 2.77% | 0.03% | Not reported | Q4 2022 | |
| $5.05M | 2.75% | 0.37% | Not reported | Q4 2025 | |
| $4.45M | 2.42% | 0.11% | +98.7% | Q1 2014 | |
| $4.22M | 2.30% | Not reported | Not reported | Q1 2024 | |
| $3.75M | 2.04% | 0.44% | Not reported | Q3 2021 | |
| $3.62M | 1.97% | 0.35% | Not reported | Q3 2024 | |
| AMAVNSAvanos Medical, Inc. | $3.48M | 1.89% | 0.30% | Not reported | Q4 2023 |
| $3.43M | 1.87% | 0.29% | Not reported | Q4 2025 | |
| $3.34M | 1.82% | 0.57% | Not reported | Q4 2025 | |
| $3.31M | 1.80% | 0.15% | -0.1% | Q3 2018 | |
| $3.11M | 1.69% | 0.37% | -0.4% | Q2 2013 | |
| $2.45M | 1.33% | 0.05% | Not reported | Q3 2022 | |
| $2.43M | 1.32% | 0.31% | Not reported | Q2 2024 | |
| $2.43M | 1.32% | 0.23% | Not reported | Q1 2023 | |
| CCCCRNCross Country Healthcare Inc | $2.21M | 1.20% | 0.52% | Not reported | Q3 2023 |
| $2.19M | 1.19% | 0.16% | Not reported | Q1 2025 | |
| $2.15M | 1.17% | 0.04% | Not reported | Q3 2014 | |
| $2.03M | 1.11% | 0.09% | New | Q2 2026 | |
| $1.81M | 0.98% | 0.13% | Not reported | Q2 2024 | |
| $1.6M | 0.87% | 0.19% | Not reported | Q2 2025 | |
| $1.21M | 0.66% | 0.27% | Not reported | Q2 2018 | |
| $1.15M | 0.63% | 0.48% | Not reported | Q3 2024 | |
| $770K | 0.42% | 0.47% | Not reported | Q3 2024 | |
| Q1 2026Reported May 5, 202639 positions | |||||
| $11.2M | 6.69% | 0.43% | -1.1% | Q3 2023 | |
| TPTPHTri Pointe Homes, Inc. | $10.3M | 6.14% | 0.26% | -0.7% | Q2 2022 |
| $8.1M | 4.84% | 0.34% | -0.7% | Q4 2024 | |
| $8.1M | 4.83% | 0.17% | -1.0% | Q2 2023 | |
| $6.84M | 4.08% | 0.21% | -0.8% | Q4 2023 | |
| $6.61M | 3.95% | 0.22% | -0.7% | Q4 2025 | |
| $6.29M | 3.76% | 0.16% | -0.7% | Q1 2015 | |
| $6.08M | 3.63% | 0.44% | -0.6% | Q3 2025 | |
| $5.49M | 3.28% | 0.22% | -0.7% | Q2 2013 | |
| $5.45M | 3.26% | 0.14% | -0.6% | Q2 2022 | |
| $5.41M | 3.23% | 0.16% | -0.9% | Q1 2021 | |
| $5.37M | 3.21% | 0.41% | New | Q1 2026 | |
| $5.21M | 3.11% | 0.37% | -0.5% | Q4 2025 | |
| $5.13M | 3.06% | 0.03% | -1.1% | Q4 2022 | |
| $4.76M | 2.84% | 0.34% | Not reported | Q4 2025 | |
| $4.75M | 2.83% | 0.35% | -0.6% | Q3 2024 | |
| $4.37M | 2.61% | 0.32% | -0.8% | Q1 2015 | |
| $4.37M | 2.61% | 0.22% | -0.7% | Q1 2025 | |
| $4.27M | 2.55% | 0.21% | New | Q1 2026 | |
| $4.15M | 2.48% | 0.15% | -0.6% | Q3 2018 | |
| $3.7M | 2.21% | 0.28% | +90.3% | Q4 2025 | |
| $3.6M | 2.15% | Not reported | -0.8% | Q1 2024 | |
| $3.39M | 2.03% | 0.17% | -1.3% | Q3 2020 | |
| $3.27M | 1.95% | 0.18% | -0.8% | Q2 2025 | |
| $3.23M | 1.93% | 0.43% | -0.4% | Q3 2021 | |
| $2.99M | 1.79% | 0.37% | Not reported | Q2 2013 | |
| $2.67M | 1.60% | 0.16% | -0.7% | Q1 2025 | |
| $2.63M | 1.57% | 0.06% | Not reported | Q1 2014 | |
| $2.48M | 1.48% | 0.53% | -0.6% | Q4 2025 | |
| $2.39M | 1.43% | 0.07% | New | Q1 2026 | |
| $2.36M | 1.41% | 0.13% | -0.8% | Q2 2024 | |
| $2.15M | 1.28% | 0.23% | -0.7% | Q1 2023 | |
| $2.12M | 1.27% | 0.31% | -0.9% | Q2 2024 | |
| $2.1M | 1.26% | 0.05% | Not reported | Q3 2022 | |
| AMAVNSAvanos Medical, Inc. | $1.96M | 1.17% | 0.30% | -0.9% | Q4 2023 |
| CCCCRNCross Country Healthcare Inc | $1.57M | 0.94% | 0.53% | -0.9% | Q3 2023 |
| $1.18M | 0.70% | 0.48% | -0.5% | Q3 2024 | |
| $901K | 0.54% | 0.27% | Not reported | Q2 2018 | |
| $518K | 0.31% | 0.48% | Not reported | Q3 2024 | |
| Q4 2025Reported Feb 3, 202640 positions | |||||
| $10.4M | 5.88% | 0.44% | -3.4% | Q3 2023 | |
| $8.63M | 4.89% | 0.33% | -3.4% | Q3 2024 | |
| $8.28M | 4.70% | 0.17% | -3.2% | Q2 2023 | |
| $7.86M | 4.46% | 0.21% | -3.6% | Q2 2013 | |
| TPTPHTri Pointe Homes, Inc. | $6.97M | 3.95% | 0.26% | -3.4% | Q2 2022 |
| $6.94M | 3.93% | 0.14% | -3.5% | Q1 2022 | |
| $6.55M | 3.71% | 0.16% | -3.4% | Q1 2015 | |
| $6.46M | 3.66% | 0.34% | -3.5% | Q4 2024 | |
| $6.03M | 3.42% | 0.21% | -3.5% | Q4 2023 | |
| $5.93M | 3.36% | 0.22% | New | Q4 2025 | |
| $5.91M | 3.35% | 0.16% | -3.5% | Q1 2021 | |
| $5.61M | 3.18% | 0.18% | -3.4% | Q2 2025 | |
| $5.6M | 3.18% | 0.29% | New | Q4 2025 | |
| $5.46M | 3.10% | 0.03% | -3.9% | Q4 2022 | |
| $4.93M | 2.79% | 0.14% | -3.5% | Q2 2022 | |
| $4.78M | 2.71% | 0.45% | -3.4% | Q3 2025 | |
| $4.72M | 2.68% | 0.22% | -3.5% | Q1 2025 | |
| $4.64M | 2.63% | 0.33% | New | Q4 2025 | |
| $4.35M | 2.46% | 0.15% | -3.4% | Q3 2018 | |
| $4.2M | 2.38% | 0.32% | -3.5% | Q1 2015 | |
| $4.09M | 2.32% | 0.16% | -3.5% | Q1 2025 | |
| $3.97M | 2.25% | 0.36% | New | Q4 2025 | |
| $3.9M | 2.21% | 0.13% | -3.3% | Q2 2024 | |
| $3.78M | 2.14% | Not reported | -3.4% | Q1 2024 | |
| $3.75M | 2.13% | 0.52% | New | Q4 2025 | |
| TFTHSTreeHouse Foods, Inc. | $3.75M | 2.13% | 0.31% | -3.5% | Q1 2018 |
| $3.54M | 2.01% | 0.34% | -3.5% | Q3 2025 | |
| $3.03M | 1.72% | 0.37% | -3.4% | Q2 2013 | |
| $2.97M | 1.68% | 0.18% | -3.4% | Q3 2020 | |
| $2.72M | 1.54% | 0.14% | New | Q4 2025 | |
| $2.27M | 1.29% | 0.43% | -3.5% | Q3 2021 | |
| $2.25M | 1.28% | 0.32% | -3.5% | Q2 2024 | |
| $2.23M | 1.26% | 0.05% | -2.6% | Q3 2022 | |
| $2.11M | 1.20% | 0.23% | -3.3% | Q1 2023 | |
| $1.95M | 1.11% | Not reported | -3.3% | Q2 2024 | |
| AMAVNSAvanos Medical, Inc. | $1.58M | 0.90% | 0.30% | -3.4% | Q4 2023 |
| $1.38M | 0.78% | 0.48% | -3.4% | Q3 2024 | |
| CCCCRNCross Country Healthcare Inc | $1.37M | 0.77% | 0.53% | -3.3% | Q3 2023 |
| $809K | 0.46% | 0.27% | -3.7% | Q2 2018 | |
| $743K | 0.42% | 0.48% | -3.8% | Q3 2024 | |
| Q3 2025Reported Nov 12, 202540 positions | |||||
| $9.85M | 5.55% | 0.44% | Not reported | Q3 2023 | |
| $8.41M | 4.74% | 0.18% | Not reported | Q2 2023 | |
| $8.38M | 4.72% | 0.34% | Not reported | Q3 2024 | |
| TPTPHTri Pointe Homes, Inc. | $7.8M | 4.39% | 0.27% | Not reported | Q2 2022 |
| $7.61M | 4.29% | 0.14% | Not reported | Q2 2022 | |
| $7.23M | 4.08% | 0.15% | Not reported | Q1 2022 | |
| $7.1M | 4.00% | 0.31% | Not reported | Q3 2024 | |
| $6.44M | 3.63% | 0.22% | Not reported | Q4 2023 | |
| $6.31M | 3.56% | 0.17% | Not reported | Q1 2015 | |
| $6.23M | 3.51% | 0.18% | Not reported | Q2 2025 | |
| $5.8M | 3.27% | 0.03% | Not reported | Q4 2022 | |
| $5.51M | 3.11% | 0.15% | Not reported | Q4 2024 | |
| $5.02M | 2.83% | 0.17% | Not reported | Q1 2021 | |
| $4.96M | 2.80% | 0.22% | Not reported | Q2 2013 | |
| $4.88M | 2.75% | 0.47% | New | Q3 2025 | |
| $4.85M | 2.74% | 0.23% | Not reported | Q1 2025 | |
| $4.8M | 2.71% | 0.35% | Not reported | Q4 2024 | |
| $4.71M | 2.65% | 0.16% | Not reported | Q1 2025 | |
| $4.55M | 2.57% | 0.15% | Not reported | Q3 2018 | |
| $4.22M | 2.38% | 0.32% | Not reported | Q1 2015 | |
| $4.09M | 2.31% | 0.13% | Not reported | Q2 2024 | |
| $3.84M | 2.17% | 0.21% | Not reported | Q2 2024 | |
| $3.75M | 2.11% | Not reported | Not reported | Q1 2024 | |
| $3.59M | 2.02% | 0.36% | New | Q3 2025 | |
| $3.34M | 1.88% | 0.17% | Not reported | Q1 2024 | |
| TFTHSTreeHouse Foods, Inc. | $3.33M | 1.88% | 0.33% | Not reported | Q1 2018 |
| $3.23M | 1.82% | 0.12% | -8.2% | Q4 2023 | |
| $3.15M | 1.77% | 0.18% | Not reported | Q3 2020 | |
| $2.91M | 1.64% | 0.39% | Not reported | Q2 2013 | |
| $2.49M | 1.40% | 0.26% | Not reported | Q2 2024 | |
| CCCCRNCross Country Healthcare Inc | $2.48M | 1.40% | 0.54% | Not reported | Q3 2023 |
| $2.43M | 1.37% | 0.44% | Not reported | Q3 2021 | |
| $2.26M | 1.27% | 0.05% | Not reported | Q3 2022 | |
| $2.25M | 1.27% | 0.33% | Not reported | Q2 2024 | |
| $2.07M | 1.17% | 0.48% | Not reported | Q3 2024 | |
| $2.03M | 1.15% | 0.24% | Not reported | Q1 2023 | |
| $2.03M | 1.14% | Not reported | Not reported | Q2 2024 | |
| AMAVNSAvanos Medical, Inc. | $1.69M | 0.95% | 0.31% | Not reported | Q4 2023 |
| $1.01M | 0.57% | 0.50% | Not reported | Q3 2024 | |
| $783K | 0.44% | 0.28% | Not reported | Q2 2018 | |
Premium opens every quarter this fund has filed